INFINITI®
AutoGenomics
The company's mission is to empower clinical laboratories with an automated multiplexing MDx solution to perform molecular testing that will significantly enhance work flow, cost efficiency and turn-around time resulting in enhanced patient care.
infiniti®

The INFINITI® Analyzer is an automated, multiplexing, continuous flow, random access microarray platform that integrates all the discrete test processes such as sample handling, reagent management, hybridization, stringency and detection for the analyses of DNA into a totally self-contained system. The analyzer features a built-in confocal microscope with two lasers, a thermal stringency station and a temperature cycler for denaturing nucleic acids for allele-specific primer extension. To avoid contamination of samples or reagents, disposable pipette tips are used for each step in the assay. This eliminates the use of pumps, plumbing or tubing resulting in minimal biohazardous liquid waste.
| Name | EN | DE | FR |
INFINITI® Analyzer |
[PDF 290KB] |
[PDF 290KB] |
[PDF 300KB] |
Applications Overview |
[PDF 15KB] |
- |
[PDF 15KB] |
Applications List |
[PDF 15KB] |
- |
[PDF 15KB] |
| Name | |
The BioFilmChip® Design
|
Play |
The INFINITI® Process |
Play |
Contact
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch
Your local distributor
Order
About us
Job opportunities
Search
News
NEW OWN CALPROTECTIN REIMBURSEMENT POSITION IN SWITZERLAND
BÜHLMANN is very proud to announce that the calprotectin determination in stool starting from January 1st 2012, has an official new position in the reimb more
New Seegene DPO Movie showing how this unique and proprietary technology is working to allow innovative multiplexing.
The unique and proprietary DPO™(Dual-Priming-Oligonucleotide) technology is the corner stone for all of the Seegene products, and it is the key to achieve more
New EntroGen BRAF test (V600E/K/D) for the detection of important mutations found in melanoma on your real-time PCR instrument.
EntroGen has a new BRAF test that detects, beside the V600E mutation, also the V600K and the V600D, which are important mutations found in melanoma. more
BÜHLMANN innovations and news at the JIB
At the JIB Congress in Paris, 8th – 10th November 2011, BÜHLMANN presents the MDx products of EntroGen and AutoGenomics as well as new developments of its more
BÜHLMANN Core | BÜHLMANN Molecular | BÜHLMANN Medical | Customer Relations | About Us |
Contact |
